TEQCX
Price
$32.06
Change
+$0.11 (+0.34%)
Updated
Nov 12 closing price
Net Assets
1.2B
VTIAX
Price
$40.68
Change
+$0.20 (+0.49%)
Updated
Nov 12 closing price
Net Assets
554.27B
Interact to see
Advertisement

TEQCX vs VTIAX

Header iconTEQCX vs VTIAX Comparison
Open Charts TEQCX vs VTIAXBanner chart's image
Touchstone Non-US Equity C
Price$32.06
Change+$0.11 (+0.34%)
VolumeN/A
Net Assets1.2B
Vanguard Total Intl Stock Index Admiral
Price$40.68
Change+$0.20 (+0.49%)
VolumeN/A
Net Assets554.27B
TEQCX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
TEQCX vs. VTIAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEQCX is a StrongBuy and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. TEQCX (1.2B). VTIAX pays higher dividends than TEQCX: VTIAX (2.70) vs TEQCX (0.60). TEQCX was incepted earlier than VTIAX: TEQCX (22 years) vs VTIAX (15 years). TEQCX (2.52) is less costly to investors than VTIAX (0.09). TEQCX is a more actively managed with annual turnover of: 22.00 vs. VTIAX (3.00). TEQCX has a lower initial minimum investment than VTIAX: TEQCX (2500) vs VTIAX (3000). VTIAX (25.12) and TEQCX (24.45) have marching annual gain over last year. VTIAX return over 5 years is better than : 39.59 vs. TEQCX (34.41).
TEQCXVTIAXTEQCX / VTIAX
Total Expense Ratio1.920.092,133%
Annual Report Gross Expense Ratio2.520.092,800%
Fund Existence22 years15 years-
Gain YTD28.44628.91298%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.2B554B0%
Annual Yield % from dividends0.602.7022%
Returns for 1 year24.4525.1297%
Returns for 3 years55.4449.28113%
Returns for 5 years34.4139.5987%
Returns for 10 years55.2479.3570%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.280.21
+10.14%
Acrivon Therapeutics
MRNA26.710.30
+1.14%
Moderna
EGHAU10.55N/A
N/A
EGH Acquisition Corp.
RAMP30.46-0.42
-1.36%
LiveRamp Holdings
IMRX6.62-0.12
-1.78%
Immuneering Corp